Carlyle (CGABL) EBITDA (2011 - 2026)

Carlyle's EBITDA history runs 16 years deep, the most recent figure standing at -$140.4 million for Q1 2026.

• In Q1 2026, EBITDA fell 170.62% year-over-year to -$140.4 million; the TTM figure through Mar 2026 stood at $943.9 million (down 39.57% YoY), while the FY2025 annual figure was $1.3 billion, down 49.23% from the prior year.
• EBITDA was -$140.4 million for Q1 2026 at Carlyle, down from $500.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $819.1 million in Q3 2024 to a low of -$810.7 million in Q4 2023.
• Historically, EBITDA has averaged $227.2 million across 5 years, with a median of $199.9 million in 2022.
• The sharpest annual moves came in 2023 and 2024: EBITDA plunged 505.55% in 2023, then jumped 734.1% in 2024.
• A 5-year view of EBITDA shows it stood at $199.9 million in 2022, then slumped by 505.55% to -$810.7 million in 2023, then surged by 136.38% to $294.9 million in 2024, then jumped by 69.58% to $500.1 million in 2025, then slumped by 128.07% to -$140.4 million in 2026.
• The last three EBITDA figures came in at -$140.4 million (Q1 2026), $500.1 million (Q4 2025), and $115.6 million (Q3 2025), per Business Quant data.